Your browser doesn't support javascript.
loading
A first-in-human study of the anti-inflammatory profibrinolytic TMS-007, an SMTP family triprenyl phenol.
Moritoyo, Takashi; Nishimura, Naoko; Hasegawa, Keiko; Ishii, Shinya; Kirihara, Kenji; Takata, Munenori; Svensson, Akiko Kishi; Umeda-Kameyama, Yumi; Kawarasaki, Shuichi; Ihara, Ryoko; Sakanaka, Chie; Wakabayashi, Yurie; Niizuma, Kuniyasu; Tominaga, Teiji; Yamazaki, Tsutomu; Hasumi, Keiji.
  • Moritoyo T; Clinical Research Support Center, University of Tokyo Hospital, Tokyo, Japan.
  • Nishimura N; Division of Research and Development, TMS Co., Ltd., Tokyo, Japan.
  • Hasegawa K; Division of Research and Development, TMS Co., Ltd., Tokyo, Japan.
  • Ishii S; Department of Geriatric Medicine, University of Tokyo Hospital, Tokyo, Japan.
  • Kirihara K; Department of Neuropsychiatry, University of Tokyo Hospital, Tokyo, Japan.
  • Takata M; Disability Services Office, University of Tokyo, Tokyo, Japan.
  • Svensson AK; Clinical Research Support Center, University of Tokyo Hospital, Tokyo, Japan.
  • Umeda-Kameyama Y; Clinical Research Support Center, University of Tokyo Hospital, Tokyo, Japan.
  • Kawarasaki S; Precision Health, Department of Bioengineering, Graduate School of Engineering, University of Tokyo, Tokyo, Japan.
  • Ihara R; Department of Geriatric Medicine, University of Tokyo Hospital, Tokyo, Japan.
  • Sakanaka C; Clinical Research Support Center, University of Tokyo Hospital, Tokyo, Japan.
  • Wakabayashi Y; Unit for Early and Exploratory Clinical Department, University of Tokyo Hospital, Tokyo, Japan.
  • Niizuma K; Clinical Research Support Center, University of Tokyo Hospital, Tokyo, Japan.
  • Tominaga T; Clinical Research Support Center, University of Tokyo Hospital, Tokyo, Japan.
  • Yamazaki T; Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Hasumi K; Department of Neurosurgical Engineering and Translational Neuroscience, Tohoku University Graduate School of Biomedical Engineering, Sendai, Japan.
Br J Clin Pharmacol ; 89(6): 1809-1819, 2023 06.
Article en En | MEDLINE | ID: mdl-36562925

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrinolisina / Antifibrinolíticos Tipo de estudio: Clinical_trials Límite: Humans / Male Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrinolisina / Antifibrinolíticos Tipo de estudio: Clinical_trials Límite: Humans / Male Idioma: En Año: 2023 Tipo del documento: Article